| Hans-Günter Meyer-Thompson | Hepatitiden
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Mashiba T, Joko K, Kurosaki M, Ochi H, Osaki Y, Kojima Y, et al. (2018)
PLoS ONE 13(4): e0194704. doi.org/10.1371/journal.pone.0194704
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194704